Application 211082
- Type
- ANDA
- Sponsor
- GLENMARK PHARMS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | RANOLAZINE | RANOLAZINE | TABLET, EXTENDED RELEASE;ORAL | 500MG | No | No |
| 002 | RANOLAZINE | RANOLAZINE | TABLET, EXTENDED RELEASE;ORAL | 1GM | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 68462-319 | Ranolazine | RANOLAZINE | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-319 | Ranolazine | RANOLAZINE | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-319 | Ranolazine | RANOLAZINE | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-320 | Ranolazine | RANOLAZINE | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-320 | Ranolazine | RANOLAZINE | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-320 | Ranolazine | RANOLAZINE | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |